Trial site
The First Affiliated Hospital of Xi'an Jiao Tong University
- 29running trials
- 6closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Hepatitis B4 trials
- Lung cancer4 trials
- Amyloidosis3 trials
- Metastatic breast cancer3 trials
- ANCA-associated vasculitis2 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- Gastric and oesophageal cancer2 trials
- Obesity2 trials
- Aortic stenosis1 trial
- Atopic dermatitis (eczema)1 trial
- Bladder cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- and 12 more
- Phase
- Phase 213 trials
- Phase 311 trials
- Phase 1/24 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Not yet recruiting15 trials
- Active, not recruiting7 trials
- Recruiting7 trials
- Completed5 trials
- Withdrawn1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10 trials
- Amgen2 trials
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.2 trials
- Shanghai Henlius Biotech2 trials
- Shanghai Zhongshan Hospital2 trials
- and 16 more
Running trials
Not yet recruiting
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Not yet recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer
Recruiting
Active, not recruiting
Active, not recruiting
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
Not yet recruiting
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
Not yet recruiting
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Recruiting
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis3 recruiting
- Gastric and oesophageal cancer2 recruiting
- Lung cancer2 recruiting
- ANCA-associated vasculitis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bladder cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Hepatitis B1 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Pancreatic cancer1 recruiting
- Stroke1 recruiting
- Thyroid cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
Withdrawn
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026